Search research articles
Contact Us
Filters
Showing results (521-530 of 874) with videos related to
Page
of 88
Sort By:
Plos One
|
June 24, 2011
Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe
Mqondisi Tshabalala, Justen Manasa, Lynn S Zijenah, et al.
BMC Public Health
|
February 10, 2011
Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study
Ziad El-Khatib, Anna Mia Ekstrom, Ashraf Coovadia, et al.
Antiviral Therapy
|
February 6, 2004
A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors
Ole Kirk, Jens D Lundgren, Court Pedersen, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1992
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment
D A Katzenstein, M Holodniy, D M Israelski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 6, 2014
Drug susceptibility and resistance mutations after first-line failure in resource limited settings
Carole L Wallis, Evgenia Aga, Heather Ribaudo, et al.
Nature Communications
|
March 8, 2024
The influence of anthropogenic regulation and evaporite dissolution on earthquake-triggered ground failure
Paula Bürgi, Eric M Thompson, Kate E Allstadt, et al.
Human Immunology
|
October 24, 2002
Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, Zimbabwe
Lynn S Zijenah, Wendy E Hartogensis, David A Katzenstein, et al.
Pediatric Blood & Cancer
|
February 8, 2011
The use of zoledronic acid in pediatric cancer patients
Keith J August, Amanda Dalton, Howard M Katzenstein, et al.
AIDS Research and Human Retroviruses
|
August 10, 2000
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group
D A Katzenstein, M Hughes, M Albrecht, et al.
Plos One
|
January 31, 2015
HIV drug resistance mutations in proviral DNA from a community treatment program
Anne Derache, Hyoung-Shik Shin, Maya Balamane, et al.
Page
of 88
Search research articles
Search
Showing results (521-530 of 874) with videos related to
Sort By:
Page
of 88
Plos One
|
June 24, 2011
Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe
Mqondisi Tshabalala, Justen Manasa, Lynn S Zijenah, et al.
BMC Public Health
|
February 10, 2011
Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study
Ziad El-Khatib, Anna Mia Ekstrom, Ashraf Coovadia, et al.
Antiviral Therapy
|
February 6, 2004
A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors
Ole Kirk, Jens D Lundgren, Court Pedersen, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1992
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment
D A Katzenstein, M Holodniy, D M Israelski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 6, 2014
Drug susceptibility and resistance mutations after first-line failure in resource limited settings
Carole L Wallis, Evgenia Aga, Heather Ribaudo, et al.
Nature Communications
|
March 8, 2024
The influence of anthropogenic regulation and evaporite dissolution on earthquake-triggered ground failure
Paula Bürgi, Eric M Thompson, Kate E Allstadt, et al.
Human Immunology
|
October 24, 2002
Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, Zimbabwe
Lynn S Zijenah, Wendy E Hartogensis, David A Katzenstein, et al.
Pediatric Blood & Cancer
|
February 8, 2011
The use of zoledronic acid in pediatric cancer patients
Keith J August, Amanda Dalton, Howard M Katzenstein, et al.
AIDS Research and Human Retroviruses
|
August 10, 2000
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group
D A Katzenstein, M Hughes, M Albrecht, et al.
Plos One
|
January 31, 2015
HIV drug resistance mutations in proviral DNA from a community treatment program
Anne Derache, Hyoung-Shik Shin, Maya Balamane, et al.
Page
of 88